161 related articles for article (PubMed ID: 9420693)
1. Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.
Geltman EM
J Nucl Cardiol; 1994; 1(2 Pt 2):S15-22. PubMed ID: 9420693
[TBL] [Abstract][Full Text] [Related]
2. Metabolic imaging of patients with cardiomyopathy.
Geltman EM
Circulation; 1991 Sep; 84(3 Suppl):I265-72. PubMed ID: 1884495
[TBL] [Abstract][Full Text] [Related]
3. Assessment of myocardial metabolism with 11C-palmitate. Comparison with 123I-heptadecanoic acid.
Lerch RA; Bergmann SR
Eur Heart J; 1985 Aug; 6 Suppl B():21-7. PubMed ID: 3878785
[TBL] [Abstract][Full Text] [Related]
4. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
5. Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency).
Kelly DP; Mendelsohn NJ; Sobel BE; Bergmann SR
Am J Cardiol; 1993 Mar; 71(8):738-44. PubMed ID: 8447275
[TBL] [Abstract][Full Text] [Related]
6. Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.
Grover-McKay M; Schelbert HR; Schwaiger M; Sochor H; Guzy PM; Krivokapich J; Child JS; Phelps ME
Circulation; 1986 Aug; 74(2):281-92. PubMed ID: 3731419
[TBL] [Abstract][Full Text] [Related]
7. [Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart].
Kaiser KP; Feinendegen LE
Herz; 1987 Feb; 12(1):41-50. PubMed ID: 3493962
[TBL] [Abstract][Full Text] [Related]
8. Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.
Geltman EM; Smith JL; Beecher D; Ludbrook PA; Ter-Pogossian MM; Sobel BE
Am J Med; 1983 May; 74(5):773-85. PubMed ID: 6601460
[TBL] [Abstract][Full Text] [Related]
9. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy.
Sochor H; Schelbert HR; Schwaiger M; Henze E; Phelps ME
Eur J Nucl Med; 1986; 12 Suppl():S66-9. PubMed ID: 3490381
[TBL] [Abstract][Full Text] [Related]
10. Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography.
Vanoverschelde JL; Wijns W; Kolanowski J; Bol A; Decoster PM; Michel C; Cogneau M; Heyndrickx GR; Essamri B; Melin JA
Am J Physiol; 1993 Mar; 264(3 Pt 2):H701-7. PubMed ID: 8456973
[TBL] [Abstract][Full Text] [Related]
11. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction.
Schelbert HR; Henze E; Sochor H; Grossman RG; Huang SC; Barrio JR; Schwaiger M; Phelps ME
Am Heart J; 1986 Jun; 111(6):1055-64. PubMed ID: 3487240
[TBL] [Abstract][Full Text] [Related]
12. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
13. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.
Brown M; Marshall DR; Sobel BE; Bergmann SR
Circulation; 1987 Sep; 76(3):687-96. PubMed ID: 3113765
[TBL] [Abstract][Full Text] [Related]
14. Significance of myocardial uptake of iodine 123-labeled beta-methyl iodophenyl pentadecanoic acid: comparison with kinetics of carbon 11-labeled palmitate in positron emission tomography.
Kawamoto M; Tamaki N; Yonekura Y; Magata Y; Tadamura E; Nohara R; Matsumori A; Sasayama S; Konishi J
J Nucl Cardiol; 1994; 1(6):522-8. PubMed ID: 9420746
[TBL] [Abstract][Full Text] [Related]
15. Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy.
Bergmann SR; Herrero P; Sciacca R; Hartman JJ; Rubin PJ; Hickey KT; Epstein S; Kelly DP
J Inherit Metab Dis; 2001 Nov; 24(6):657-74. PubMed ID: 11768585
[TBL] [Abstract][Full Text] [Related]
16. [Fatty acid metabolism using C-11 palmitate: (1). Resting study].
Tamaki N; Yonekura Y; Magata Y; Saji H; Fujibayashi Y; Sasayama S; Yamashita K; Ohtani H; Fujita T; Yamada T
Kaku Igaku; 1990 Apr; 27(4):313-21. PubMed ID: 2376917
[TBL] [Abstract][Full Text] [Related]
17. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically.
Fox KA; Abendschein DR; Ambos HD; Sobel BE; Bergmann SR
Circ Res; 1985 Aug; 57(2):232-43. PubMed ID: 4017196
[TBL] [Abstract][Full Text] [Related]
18. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium.
Armbrecht JJ; Buxton DB; Schelbert HR
Circulation; 1990 May; 81(5):1594-605. PubMed ID: 2110037
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.
Brown MA; Myears DW; Bergmann SR
J Am Coll Cardiol; 1988 Oct; 12(4):1054-63. PubMed ID: 3262128
[TBL] [Abstract][Full Text] [Related]
20. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]